Market Tracker

02/17 5:16pm ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

2.54
Delayed Data
As of Feb 17
 -0.25 / -8.96%
Today’s Change
1.65
Today|||52-Week Range
4.90
+1.60%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close2.79
Today’s open2.81
Day’s range2.50 - 2.82
Volume142,581
Average volume (3 months)106,702
Market cap$47.3M
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-49.55%
Earnings growth (this year)+20.48%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+485.21%
P/E ratioNM
Price/Sales6.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
THLDThreshold Pharmaceut...-0.02-3.06%
EBIOEleven Biotherapeuti...+0.04+1.96%
GLMDGalmed Pharmaceutica...-0.01-0.24%
ITEKInotek Pharmaceutica...+0.02+1.56%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$9.7M
Annual profit (last year)-$15.9M
Net profit margin-163.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Vice President-
Operations
Clayton D. Edwards
Corporate headquarters
San Diego, California

Forecasts